1 study found for:    ARD10248
Show Display Options
Rank Status Study
1 Active, not recruiting SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients
Condition: Diffuse Large B-cell Lymphoma
Intervention: Drug: SAR3419

Indicates status has not been verified in more than two years